<DOC>
	<DOCNO>NCT02306837</DOCNO>
	<brief_summary>To imporve outcome patient relapsed/refractory lymphoma , conduct clinical trial test efficacy feasibility consolidation chemotherapy autologous stem cell transplantation</brief_summary>
	<brief_title>Consolidation Chemotherapy After Autologous Stem Cell Transplantation Lymphoid Malignancies</brief_title>
	<detailed_description>Patients relapse refractory lymphoma include . All patient undergo PBSC mobilization CTX G-CSF . After sucessful collection CD34+ 1x109/L , autologous stem cel ltransplantation Bu-Cy-E conditioning give . Two month auto-HSCT , PET-CT perform patient CR , CRu PR recieved 3 cycle mini-Bu-Cy-E consolidation 3 , 6 9 month auto-HSCT . For patient SD PD auto-HSCT refer allogeneic transplantatio program take study .</detailed_description>
	<criteria>Patients relapse refracotry NHL HD : PR SD first line salvage chemotherapy ; ECOG : 02 Tbil &lt; 1.5x ULN AST/ALT &lt; 2.5x ULN With informed consent Life expectancy &lt; 3 month Women pregnancy uncontrollable infection disease serum Cr &gt; 400mmol/l uncontroled diabetis heart disease</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>lymphoma , consolidation chemotherapy , auto-HSCT</keyword>
</DOC>